FDA Adverse Event Malfunction Summary report: N

ACCESS FREE T3 REAGENT

MDR report key: 5514409 · Received March 21, 2016

Report

Report Number
8020879-2016-00019
Event Type
Malfunction
Date Received
March 21, 2016
Date of Event
January 5, 2016
Report Date
March 1, 2016
Manufacturer
BECKMAN COULTER IRELAND
Product Code
CDP
PMA / PMN Number
EXEMPT
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CUSTOMER DID NOT SUPPLY ANY PATIENT DEMOGRAPHICS SUCH AS AGE, DATE OF BIRTH, SEX OR WEIGHT. (B)(6). A BECKMAN COULTER (BEC) FIELD SERVICE ENGINEER (FSE) WAS NOT DISPATCHED TO THE CUSTOMER'S SITE. NO HARDWARE ERRORS, FLAGS OR OTHER ASSAY ISSUES WERE REPORTED IN CONJUNCTION WITH THIS EVENT. THERE IS NO EVIDENCE THAT THE ACCESS FREE T3 REAGENT WAS RETURNED FOR EVALUATION. IN CONCLUSION, THE CAUSE OF THE EVENT CANNOT BE DETERMINED WITH THE AVAILABLE INFORMATION. ALL MDRS ASSOCIATED WITH THIS REPORT ARE: 8020879-2016-00014, 8020879-2016-00015, 8020879-2016-00016, 8020879-2016-00017, 8020879-2016-00018, 8020879-2016-00019. (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTED OBTAINING AN ELEVATED FREE TRIIODOTHYRONINE (ACCESS FREE T3) RESULT FOR ONE PATIENT ON THE UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM (SERIAL NUMBER (B)(4)) THAT WAS DISCORDANT TO ANOTHER METHODOLOGY AND THE PATIENT'S CLINICAL FILE. THE SAMPLE WAS REPEATED AND A SIMILAR ELEVATED RESULT, ABOVE THE ASSAY'S NORMAL REFERENCE RANGE WAS OBTAINED. THE PATIENT'S FREE THYROXIN (ACCESS FREE T4) AND THE PATIENT'S HUMAN THYROID-STIMULATING HORMONE (ACCESS HTSH) RESULTS WERE WITHIN NORMAL REFERENCE RANGES. THE CUSTOMER ALSO ANALYZED THE PATIENT SAMPLE ON AN ALTERNATE METHODOLOGY (E602, ROCHE) AND OBTAINED A DISCORDANT, LOWER FREE TRIIODOTHYRONINE RESULT WITHIN THAT ASSAY'S NORMAL REFERENCE RANGE. THE ACCESS FREE T3 RESULT WAS REPORTED OUTSIDE THE LABORATORY. THERE WAS NO REPORT OF PATIENT INJURY OR CHANGE IN PATIENT TREATMENT ASSOCIATED WITH THIS EVENT. THIS MDR ADDRESSED THE RESULTS OBTAINED FOR ONE PATIENT ON (B)(6) 2016. 8020879-2016-00014 WILL ADDRESS THE RESULTS OBTAINED ON (B)(6) 2015. 8020879-2016-00015 WILL ADDRESS THE RESULTS OBTAINED ON (B)(6) 2015. 8020879-2016-00016 WILL ADDRESS THE RESULTS OBTAINED ON (B)(6) 2015. 8020879-2016-00017 WILL ADDRESS THE RESULTS OBTAINED ON (B)(6) 2015. 8020879-2016-00018 WILL ADDRESS THE RESULTS OBTAINED ON (B)(6) 2015. CALIBRATION, QC AND SYSTEM CHECK PARAMETERS WERE ALL RECOVERING WITHIN EXPECTED RANGES AT THE TIME OF THE EVENT. INFORMATION ON THE COLLECTION AND CENTRIFUGATION OF THE PATIENT SAMPLE WAS NOT SUPPLIED. NO ISSUES WITH SAMPLE INTEGRITY WERE REPORTED BY THE CUSTOMER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
170506 ACCESS FREE T3 REAGENT RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE CDP BECKMAN COULTER IRELAND NA 570116

Patients

Seq Age Sex Outcome Treatment
1